Registered Number 06533824

PRO MEDICAL INNOVATIONS LIMITED

Abbreviated Accounts

31 March 2012

PRO MEDICAL INNOVATIONS LIMITED Registered Number 06533824

Abbreviated Balance Sheet as at 31 March 2012

Notes 2012 2011
£ £
Called up share capital not paid - -
Fixed assets
Intangible assets - -
Tangible assets - -
Investments - -
- -
Current assets
Stocks - -
Debtors 102 1,035
Investments - -
Cash at bank and in hand 3,571 5,390
3,673 6,425
Prepayments and accrued income - -
Creditors: amounts falling due within one year (8,750) (10,400)
Net current assets (liabilities) (5,077) (3,975)
Total assets less current liabilities (5,077) (3,975)
Creditors: amounts falling due after more than one year 0 0
Provisions for liabilities 0 0
Accruals and deferred income 0 0
Total net assets (liabilities) (5,077) (3,975)
Capital and reserves
Called up share capital 2 200 200
Share premium account 14,980 14,980
Revaluation reserve 0 0
Other reserves 0 0
Profit and loss account (20,257) (19,155)
Shareholders' funds (5,077) (3,975)
  • For the year ending 31 March 2012 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
  • The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  • The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  • These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 11 March 2013

And signed on their behalf by:
D S HARPER, Director

PRO MEDICAL INNOVATIONS LIMITED Registered Number 06533824

Notes to the Abbreviated Accounts for the period ended 31 March 2012

1Accounting Policies

Basis of measurement and preparation of accounts
The accounts have been prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities effective April 2008.

Other accounting policies
RESEARCH AND DEVELOPMENT
Expenditure on research and development is written off in the year in which it is incurred.

2Called Up Share Capital
Allotted, called up and fully paid:
2012
£
2011
£
200 Ordinary shares of £1 each 200 200